Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Impact of CT-P13 and originator infliximab treatment on quality of life derived from the health assrssment questionnaire(HAQ) and a short form 36(SF36) from a randomized double blinded trial in patients with active RA
- Authors
- 유대현
- Issue Date
- 29-Oct-2013
- Place
- San Diego, CA, USA
- Conference Name
- Annual Congress of American College of Rheumatology
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.